Allogeneic T cells are genetically modified with a retroviral vector coding HSV-TK and ΔLNGFR genes so that these genes are integrated in the genome of the cells. If graft vs host disease (GvHD) occurs, the cell product can be inactivated by administrating ganciclovir. The gene discussed is TKT; the disease is graft versus host disease.